These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31701947)

  • 1. STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2012 Aug; 38(ACS-2):1-36. PubMed ID: 31701947
    [No Abstract]   [Full Text] [Related]  

  • 2. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
    Gemmill I; Zhao L; Cochrane L;
    Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on the use of live, attenuated influenza vaccine (FluMist
    This statement was prepared and approved by NACI.
    Can Commun Dis Rep; 2011 Nov; 37(ACS-7):1-77. PubMed ID: 31682654
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad
    This statement was prepared by CADTH and approved by NACI.
    Can Commun Dis Rep; 2011 Oct; 37(ACS-6):1-68. PubMed ID: 31701945
    [No Abstract]   [Full Text] [Related]  

  • 5. Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2013 Oct; 39(ACS-4):1-37. PubMed ID: 31701948
    [No Abstract]   [Full Text] [Related]  

  • 6. Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2011 Oct; 37(ACS-5):1-55. PubMed ID: 31682646
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    This statement was prepared and approved by NACI.
    Can Commun Dis Rep; 2010 Aug; 36(ACS-6):1-49. PubMed ID: 31682656
    [No Abstract]   [Full Text] [Related]  

  • 8. Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2012 Aug; 38(ACS-2):1-55. PubMed ID: 31702744
    [No Abstract]   [Full Text] [Related]  

  • 9. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.
    Can Commun Dis Rep; 2021 Sep; 47(9):372-380. PubMed ID: 34650334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.
    Vaudry W; Stirling R;
    Can Commun Dis Rep; 2017 May; 43(5):96-103. PubMed ID: 29770072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
    Tam T; Langley J;
    Can Commun Dis Rep; 2004 Mar; 30():1-5. PubMed ID: 15035403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015-2016.
    Gemmill I;
    Can Commun Dis Rep; 2015 Oct; 41(10):227-232. PubMed ID: 29769917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2001 Jan; 27():1-3. PubMed ID: 11227823
    [No Abstract]   [Full Text] [Related]  

  • 14. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Feb; 28(ACS-3):1-7. PubMed ID: 11875774
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.
    Young K; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 May; 46(5):132-137. PubMed ID: 32558810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*
    Laupland K;
    Can Commun Dis Rep; 2010 Jan; 36(ACS-1):1-19. PubMed ID: 31682655
    [No Abstract]   [Full Text] [Related]  

  • 17. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():19-20. PubMed ID: 10927839
    [No Abstract]   [Full Text] [Related]  

  • 18. Statement on Measles-Mumps-Rubella-Varicella Vaccine: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Tan B; Ismail S;
    Can Commun Dis Rep; 2010 Sep; 36(ACS-9):1-22. PubMed ID: 31682661
    [No Abstract]   [Full Text] [Related]  

  • 19. Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13): An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Quach-Thanh C; Thomas MH;
    Can Commun Dis Rep; 2013 Oct; 39(ACS-5):1-52. PubMed ID: 31682649
    [No Abstract]   [Full Text] [Related]  

  • 20. Summary of the NACI Seasonal Influenza Vaccine Statement for 2019-2020.
    Zhao L; Young K; Gemmill I
    Can Commun Dis Rep; 2019 Jun; 45(6):149-155. PubMed ID: 31285706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.